Victoria Socha

DocwireNews

Rates of delayed graft function are low in pediatric recipients of living donor kidneys. M. MacConmara and colleagues at UT Southwestern Medical Center, Dallas, Texas, conducted a study designed to assess the incidence, risk factors, and outcomes of delayed graft function in pediatric kidney transplant recipients who received a living donor allograft. Results of the study were reported in a virtual presentation at the 2021 American Transplant Congress. The presentation was titled Delayed Graft Function in Pediatric Living Donor Kidney Transplantation.The researchers queried the United Network for Organ Sharing database to identify all pediatric patients who received a living donor transplant between 2000 and 2020. The study defined <a href="https://www.docwirenews.com/nephtimes/nephtimes-conferences/american-transplant-congress-2021/risk-factors-in-long-term-graft-survival-in-pediatric-transplant-recipients/">pediatric recipient</a> as one who received the transplant prior to reaching age 18. The analysis included donor and recipient demographic data, as well as data on survival and outcomes. Delayed graft function was defined as the need for dialysis within the first week after transplant.During the study period, 6480 pediatric patients received a living donor kidney transplant. Of those 4.2% (n=269) developed delayed graft function post-transplant. Donors of patients in the two groups (delayed graft function and control) were similar in age (37.2 years vs 37.0 years, respectively), had similar preoperative creatinine (0.86 mg/dL in both groups), sex, and ethnicity. Donor body mass index (BMI) was higher in the delayed graft function group (27.6 vs 26.8 kg/m2, respectively, P=.004). Cold ischemia time was similar in both groups (2.4 vs 2.3 hours).Among recipients, both groups were similar in age (9.8 vs 10.1 years). Recipients in the delayed graft function group had higher BMI than those in the control group (20.3 vs 19.4 kg/m2; P=.002). Initial and final calculated panel-reactive antibodies were similar in the two groups (2.2% vs 2.4% initial; 10.5% vs 8.9% final). Human leukocyte antigen mismatch was also similar (3.0 vs 2.8). The most common diagnosis (23%) in recipients with delayed graft function was focal segmental glomerulosclerosis (FSGS). FSGS was significantly more frequent in the delayed graft function group than in the control group (23% vs 10%, respectively; P=.001).Recipients with body weight &lt;15 kg had a significantly higher rate of delayed graft function (24.9% vs 19.8%; P=.04). Length of stay for recipients with delayed graft function was twice that of the control group (23.4 vs 10.1 days, respectively, P&lt;.0001).At 6 and 12 months post-transplant, rates of rejection were higher among patients in the delayed graft function group than in the control group (24.8% vs 8.0% at 6 months, respectively, P&lt;.0001; 26.4% vs 11.6% at 12 months, respectively, P&lt;.0001). Those in the delayed graft function group had significantly worse allograft survival compared with the control group; 1-year graft survival was more than 30% lower in the delayed graft function group than in the control group (67% vs 98%). Graft thrombosis (25.3%), rejection (17.5%), and recurrent disease (15.6%) were the most common causes of allograft loss.In conclusion, the researchers said, &ldquo;Pediatric living donor kidney transplant recipients who experience delayed graft function have significantly poorer allograft survival. Immunologic events, recurrent disease, and technical complications appear to underlie these poor outcomes and should be considered especially in younger recipients with FSGS. Optimizing the donor recipient combination to avoid compounding risks should allow for better outcomes.&rdquo;Source: MacConmara M, Shah J, De Gregorio L, Desai D, Vagefi P, Hwang C S. Delayed graft function in pediatric living donor kidney transplantation. Abstract of a presentation at the virtual 2021 American Transplant Congress (Abstract #82), June 5, 2021.

Dr. Sadie Dobrozsi, Evolent

Rob Dillard

Genomics Tailors Breast Cancer Care, Cuts Unneeded Chemo

Genetics & Breast Cancer

Andrew Moreno

Extending Anticoagulation is Reasonable in Children with VTE, Data Suggest

Katie Kosko

DESTINY-Breast06: T-DXd Beats Chemo in HER2-Low HR+ mBC

Breast Cancer News

Latest News

Delayed Graft Function in Pediatric Kidney Transplant Recipients

American Transplant Congress 2021

Rates of delayed graft function are low in pediatric recipients of living donor kidneys. M. MacConmara and colleagues at UT Southwestern Medical Center, Dallas, Texas, ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe